Summary:
- Researchers have identified a novel biomarker in the brain that may play a significant role in the early-stage progression of Alzheimer’s disease.
- The study focuses on specific protein interactions and cellular pathways that could serve as a new target for therapeutic interventions and diagnostic screening.